Formulary
Learn More About Becoming a Provider
Read More InfoThe Abrazo Advantage Health Plan (AAHP) Drug Formulary was created to ensure safe, appropriate and cost-effective utilization of medications. With a primary consideration to provide comprehensive drug coverage for patients, the Formulary was evaluated in all therapeutic categories and contains those agents that offer the greatest value in each class. Provider's utilization of the AAHP Drug Formulary ensures our member's pharmaceutical needs are met in a high quality, cost-effective manner. Formulary development and maintenance is a dynamic process and is subject to periodic changes.
2010 Benefit Year
Abrazo Advantage (HMO) Plan
Abrazo Advantage (HMO) Formulary
Abrazo Advantage (HMO) Prior Authorization Criteria
Abrazo Advantage (HMO) Drug Quantity Level Limits
Abrazo Advantage (HMO) Step Therapy Criteria
Abrazo Advantage Plus (HMO) Plan
Abrazo Advantage Plus (HMO) Abridged Formulary
Abrazo Advantage Plus (HMO) Prior Authorization Criteria
Abrazo Advantage Plus (HMO) Drug Quantity Level Limits
Abrazo Advantage Plus (HMO) Step Therapy Criteria
Note on seasonal flu medicine: Tamiflu® is available through community pharmacies without prior authorization for children less than 6 years old and for 6-18 year olds with current prescriptions for asthma inhalers.
The AAHP Pharmacy and Therapeutics Committee
Purpose and Goals:
The AAHP Pharmacy and Therapeutic (P & T) Committee consists of physicians, pharmacists, and other professionals representing various medical specialties, whose primary purpose is to develop and monitor the AAHP Drug Formulary and to establish programs and procedures to ensure high quality, cost-effective drug therapy. The AAHP P & T regularly reviews new and existing medications to ensure the Formulary meets the needs of both members and providers.